Baye Gelaw
- Infectious Diseases top 2%
- Epidemiology top 5%
- Parasitology top 2%
- Nutrition and Dietetics top 5%
- Surgery
- Co-authors
- Aschalew GelawAbate AssefaBelay AnagawZelalem AddisYitayal ShiferawBelay TessemaAbebe AlemuTakele Teklu
- Topics
- Tuberculosis Research and Epidemiology (17 papers)Mycobacterium research and diagnosis (10 papers)Pneumocystis jirovecii pneumonia detection and treatment (7 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports
- Partner nations
- EthiopiaUnited StatesKenya
In The Last Decade
Baye Gelaw
64 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 113
- Infectious Diseases 583
- Epidemiology 494
- Parasitology 300
- Nutrition and Dietetics 286
- Surgery 239
Countries citing papers authored by Baye Gelaw
This map shows the geographic impact of Baye Gelaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baye Gelaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baye Gelaw more than expected).
Fields of papers citing papers by Baye Gelaw
This network shows the impact of papers produced by Baye Gelaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baye Gelaw. The network helps show where Baye Gelaw may publish in the future.
Co-authorship network of co-authors of Baye Gelaw
This figure shows the co-authorship network connecting the top 25 collaborators of Baye Gelaw. A scholar is included among the top collaborators of Baye Gelaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baye Gelaw. Baye Gelaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 9 | |
| 7 | 9 | |
| 8 | 2 | |
| 9 | 20 | |
| 10 | 4 | |
| 11 | 8 | |
| 12 | 20 | |
| 13 | Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia | 3 |
| 14 | 40 | |
| 15 | 52 | |
| 16 | 21 | |
| 17 | 34 | |
| 18 | 44 | |
| 19 | 30 | |
| 20 | 41 |
About Baye Gelaw
Baye Gelaw is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Endocrinology, having authored 64 papers that have together received 1.5k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (17 papers), Mycobacterium research and diagnosis (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). The work is most often cited by research in Parasitology (300 citations), Infectious Diseases (583 citations) and Applied Microbiology and Biotechnology (62 citations). Baye Gelaw has collaborated with scholars based in Ethiopia, United States and Kenya. Frequent co-authors include Aschalew Gelaw, Abate Assefa, Belay Anagaw, Zelalem Addis, Yitayal Shiferaw, Belay Tessema, Abebe Alemu, Takele Teklu, Agumas Shibabaw and Meseret Alem. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.